Literature DB >> 23843027

Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction.

Manuela Cabiati1, Alessandro Martino, Letizia Mattii, Chiara Caselli, Tommaso Prescimone, Vincenzo Lionetti, Maria-Aurora Morales, Silvia Del Ry.   

Abstract

Adenosine, a purine nucleoside and a "retaliatory metabolite" in ischemia, is ubiquitous in the body and increases 100-fold during ischemia. Its biological actions are mediated by four adenosine receptors (ARs): A(1), A(2A), A(2B) and A(3). The aim of this study was to determine possible myocardial alterations in AR expression in an experimental animal model of myocardial infarction (MI) with a preserved left ventricular (LV) ejection fraction. LV tissue was collected from sexually mature male farm pigs with MI (n = 6) induced by permanent surgical ligation of the left anterior descending coronary artery and from five healthy pigs (C). mRNA expression of A(1)R, A(2A)R, A(2B)R, A(3)R and TNF-α was determined by real-time PCR in tissue collected from border (BZ) and remote zones (RZ) of the infarcted area and from LV of C. BZ, RZ and samples of C were stained immunohistochemically to investigate A(3)R immunoreaction. After 4 weeks a different regulation of ARs was observed. A(1)R mRNA expression was significantly lower in the infarct regions than in controls (C = 0.75 ± 0.2, BZ = 0.05 ± 0.2, RZ = 0.07 ± 0.02 p = 0.0025, p = 0.0016, C vs. BZ and RZ, respectively). Conversely A(3)R was higher in infarct areas (C = 0.94 ± 0.2, BZ = 2.85 ± 0.5, RZ = 3.48 ± 1.0, p = 0.048 C vs. RZ). No significant differences were observed for A(2A)R (C = 1.58 ± 0.6, BZ = 0.42 ± 0.1, RZ = 1.37 ± 0.6) and A(2B)R (C = 1.66 ± 0.2, BZ = 1.54 ± 0.5, RZ = 1.25 ± 0.4). A(3)R expression was confirmed by immunohistochemical analysis and was principally localized in cardiomyocytes. TNF-α mRNA results were: C 0.41 ± 0.25; BZ 1.60 ± 0.19; RZ 0.17 ± 0.04. The balance between A(1)R and A(3)R as well as between A(2A)R and A(2B)R was consistent with adaptative retaliatory anti-ischemic adenosinergic changes in the infarcted heart with preserved LV function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23843027     DOI: 10.1007/s00380-013-0380-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  38 in total

Review 1.  Purinergic signaling and vascular cell proliferation and death.

Authors:  Geoffrey Burnstock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

2.  Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation.

Authors:  D L Boyle; F G Sajjadi; G S Firestein
Journal:  Arthritis Rheum       Date:  1996-06

3.  Internalization and desensitization of adenosine receptors.

Authors:  Elisabeth C Klaasse; Adriaan P Ijzerman; Willem J de Grip; Margot W Beukers
Journal:  Purinergic Signal       Date:  2007-11-13       Impact factor: 3.765

Review 4.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

5.  Supply-to-demand ratio for oxygen determines formation of adenosine by the heart.

Authors:  H Bardenheuer; J Schrader
Journal:  Am J Physiol       Date:  1986-02

Review 6.  Signalling from adenosine receptors to mitogen-activated protein kinases.

Authors:  Gunnar Schulte; Bertil B Fredholm
Journal:  Cell Signal       Date:  2003-09       Impact factor: 4.315

Review 7.  Adenosine in fibrosis.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Mod Rheumatol       Date:  2009-12-01       Impact factor: 3.023

8.  Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.

Authors:  M J de Boer; H Suryapranata; J C Hoorntje; S Reiffers; A L Liem; K Miedema; W T Hermens; M J van den Brand; F Zijlstra
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

9.  Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure.

Authors:  Silvia Del Ry; Manuela Cabiati; Vincenzo Lionetti; Anca Simioniuc; Chiara Caselli; Tommaso Prescimone; Michele Emdin; Daniela Giannessi
Journal:  Peptides       Date:  2009-06-21       Impact factor: 3.750

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  5 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction.

Authors:  Xiaoqiang Liu; Jianshu Gao; Qiang Xia; Tianfei Lu; Fang Wang
Journal:  Heart Vessels       Date:  2016-01-11       Impact factor: 2.037

3.  Acute changes of left ventricular hemodynamics and function during percutaneous coronary intervention in patients with unprotected left main coronary artery disease.

Authors:  Seong-Mi Park; Chul-Min Ahn; Soon-Jun Hong; Yong-Hyun Kim; Jae-Hyoung Park; Wan-Joo Shim; Do-Sun Lim
Journal:  Heart Vessels       Date:  2014-03-15       Impact factor: 2.037

4.  Intramyocardial delivery of VEGF165 via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction.

Authors:  Hongling Zhu; Xuejun Jiang; Xiaoyan Li; Miaoyang Hu; Weiguo Wan; Ying Wen; Yiyu He; Xiaoxin Zheng
Journal:  Heart Vessels       Date:  2015-07-04       Impact factor: 2.037

5.  Adenosine A2A receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction.

Authors:  Jaqueline S da Silva; Daniele Gabriel-Costa; Roberto T Sudo; Hao Wang; Leanne Groban; Emanuele B Ferraz; José Hamilton M Nascimento; Carlos Alberto M Fraga; Eliezer J Barreiro; Gisele Zapata-Sudo
Journal:  Drug Des Devel Ther       Date:  2017-03-06       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.